Literature DB >> 25677400

Ginkgolide B revamps neuroprotective role of apurinic/apyrimidinic endonuclease 1 and mitochondrial oxidative phosphorylation against Aβ25-35 -induced neurotoxicity in human neuroblastoma cells.

Navrattan Kaur1, Monisha Dhiman, J Regino Perez-Polo, Anil K Mantha.   

Abstract

Accumulating evidence points to roles for oxidative stress, amyloid beta (Aβ), and mitochondrial dysfunction in the pathogenesis of Alzheimer's disease (AD). In neurons, the base excision repair pathway is the predominant DNA repair (BER) pathway for repairing oxidized base lesions. Apurinic/apyrimidinic endonuclease 1 (APE1), a multifunctional enzyme with DNA repair and reduction-oxidation activities, has been shown to enhance neuronal survival after oxidative stress. This study seeks to determine 1) the effect of Aβ25-35 on reactive oxygen species (ROS)/reactive nitrogen species (RNS) levels, 2) the activities of respiratory complexes (I, III, and IV), 3) the role of APE1 by ectopic expression, and 4) the neuromodulatory role of ginkgolide B (GB; from the leaves of Ginkgo biloba). The pro-oxidant Aβ25-35 peptide treatment increased the levels of ROS/RNS in human neuroblastoma IMR-32 and SH-SY5Y cells, which were decreased after pretreatment with GB. Furthermore, the mitochondrial APE1 level was found to be decreased after treatment with Aβ25-35 up to 48 hr, and the level was increased significantly in cells pretreated with GB. The oxidative phosphorylation (OXPHOS; activities of complexes I, III, and IV) indicated that Aβ25-35 treatment decreased activities of complexes I and IV, and pretreatment with GB and ectopic APE1 expression enhanced these activities significantly compared with Aβ25-35 treatment. Our results indicate that ectopic expression of APE1 potentiates neuronal cells to overcome the oxidative damage caused by Aβ25-35 . In addition, GB has been shown to modulate the mitochondrial OXPHOS against Aβ25-35 -induced oxidative stress and also to regulate the levels of ROS/RNS in the presence of ectopic APE1. This study presents findings from a new point of view to improve therapeutic potential for AD via the synergistic neuroprotective role played by APE1 in combination with the phytochemical GB.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  APE1; Alzheimer's disease; Aβ25-35; OXPHOS; Ref-1; amyloid beta; ginkgolide B

Mesh:

Substances:

Year:  2015        PMID: 25677400     DOI: 10.1002/jnr.23565

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  22 in total

1.  Secretome Cues Modulate the Neurogenic Potential of Bone Marrow and Dental Stem Cells.

Authors:  Ajay Kumar; Vinod Kumar; Vidya Rattan; Vivekanand Jha; Shalmoli Bhattacharyya
Journal:  Mol Neurobiol       Date:  2016-07-15       Impact factor: 5.590

2.  Identification of ginkgolide targets in brain by photoaffinity labeling.

Authors:  Akira Kawamura; Ilyas Washington; Doina M Mihai; Francesca Bartolini; Gregg G Gundersen; Milica Tesic Mark; Koji Nakanishi
Journal:  Chem Biol Drug Des       Date:  2016-11-10       Impact factor: 2.817

Review 3.  Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisal.

Authors:  Chandra Sekhar Kuruva; P Hemachandra Reddy
Journal:  Drug Discov Today       Date:  2016-10-27       Impact factor: 7.851

4.  [Gly14]-Humanin Protects Against Amyloid β Peptide-Induced Impairment of Spatial Learning and Memory in Rats.

Authors:  Li Yuan; Xiao-Jie Liu; Wei-Na Han; Qing-Shan Li; Zhao-Jun Wang; Mei-Na Wu; Wei Yang; Jin-Shun Qi
Journal:  Neurosci Bull       Date:  2016-06-15       Impact factor: 5.203

5.  PTEN-mediated mitophagy and APE1 overexpression protects against cardiac hypoxia/reoxygenation injury.

Authors:  Wenshuai Tang; Deqing Lin; Mingxiang Chen; Zhiping Li; Weimin Zhang; Wenping Hu; Fuping Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-08-20       Impact factor: 2.416

Review 6.  Nutrition, Physical Activity, and Other Lifestyle Factors in the Prevention of Cognitive Decline and Dementia.

Authors:  Ligia J Dominguez; Nicola Veronese; Laura Vernuccio; Giuseppina Catanese; Flora Inzerillo; Giuseppe Salemi; Mario Barbagallo
Journal:  Nutrients       Date:  2021-11-15       Impact factor: 5.717

Review 7.  The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.

Authors:  Niklas Reich; Christian Hölscher
Journal:  Front Neurosci       Date:  2022-09-01       Impact factor: 5.152

8.  Curcumin revitalizes Amyloid beta (25-35)-induced and organophosphate pesticides pestered neurotoxicity in SH-SY5Y and IMR-32 cells via activation of APE1 and Nrf2.

Authors:  Bibekananda Sarkar; Monisha Dhiman; Sunil Mittal; Anil K Mantha
Journal:  Metab Brain Dis       Date:  2017-08-31       Impact factor: 3.584

Review 9.  Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders.

Authors:  Sandeep Kumar Singh; Saurabh Srivastav; Rudolph J Castellani; Germán Plascencia-Villa; George Perry
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

10.  Regulation of Rac1 and Reactive Oxygen Species Production in Response to Infection of Gastrointestinal Epithelia.

Authors:  Gerco den Hartog; Ranajoy Chattopadhyay; Amber Ablack; Emily H Hall; Lindsay D Butcher; Asima Bhattacharyya; Lars Eckmann; Paul R Harris; Soumita Das; Peter B Ernst; Sheila E Crowe
Journal:  PLoS Pathog       Date:  2016-01-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.